Cargando…
Xanomeline Protects Cortical Cells From Oxygen-Glucose Deprivation via Inhibiting Oxidative Stress and Apoptosis
Xanomeline, a muscarinic acetylcholine receptor agonist, is one of the first compounds that was found to be effective in the treatment of schizophrenics and attenuating behavioral disturbances of patients with Alzheimer’s disease (AD). However, its role in ischemia-induced injury due to oxygen and g...
Autores principales: | Xin, Rujuan, Chen, Zhongjian, Fu, Jin, Shen, Fuming, Zhu, Quangang, Huang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303960/ https://www.ncbi.nlm.nih.gov/pubmed/32595528 http://dx.doi.org/10.3389/fphys.2020.00656 |
Ejemplares similares
-
Mitochondrial BK(Ca) Mediates the Protective Effect of Low-Dose Ethanol Preconditioning on Oxygen-Glucose Deprivation and Reperfusion-Induced Neuronal Apoptosis
por: Su, Fang, et al.
Publicado: (2021) -
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023) -
Oxygen Glucose Deprivation Induced Prosurvival Autophagy Is Insufficient to Rescue Endothelial Function
por: Natarajan, Venkateswaran, et al.
Publicado: (2020) -
Silencing Huwe1 reduces apoptosis of cortical neurons exposed to oxygen-glucose deprivation and reperfusion
por: He, Guo-Qian, et al.
Publicado: (2019) -
Corrigendum: Silencing Huwe1 reduces apoptosis of cortical neurons exposed to oxygen-glucose deprivation and reperfusion
Publicado: (2020)